Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2-Reference-Cited by-同舟云学术

Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2

Published:2021-12-30 Issue:1 Volume:13 Page:455-468
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhang Yue¹²³⁴⁵,Wang Yaoyi⁶⁷,Xue Jun⁸,Liang Wanping⁸,Zhang Zhisheng⁸,Yang Xiuming⁸,Qiao Zhifei⁸,Jiang Yang⁸,Wang Junping⁶,Cao Xuchen²³⁴⁵⁹,Chen Peng¹²³⁴⁵

Affiliation:

1. Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

2. National Clinical Research Center for Cancer, Tianjin, China

3. Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

4. Tianjin’s Clinical Research Center for Cancer, Tianjin, China

5. Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China

6. Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China

7. Tianjin Key Laboratory of Functional Imaging, Tianjin, China

8. Department of Mammography Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China

9. Lung Cancer Diagnosis and Treatment Center, Tianjin, China

Funder

Zhangjiakou City Self-financing

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2009410

Reference51 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer

3. Breast cancer statistics, 2017, racial disparity in mortality by state

4. Molecular genetics complexity impeding research progress in breast and ovarian cancers

5. Breast cancer statistics, 2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunities;Pathology - Research and Practice;2024-10

2. Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1;Journal of Bone Oncology;2024-06

3. Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals;Frontiers in Immunology;2024-05-14

4. Transcription factor STAT4 counteracts radiotherapy resistance in breast carcinoma cells by activating the MALAT1/miR-21-5p/THRB regulatory network;American Journal of Cancer Research;2024

5. The ceRNA Mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer;Critical Reviews in Eukaryotic Gene Expression;2024